Systematic review of breast cancer biology in developing countries (part 1): Africa, the Middle East, Eastern Europe, Mexico, the Caribbean and South America

Cancers

Volumn 3, Issue 2, 2011, Pages 2358-2381

  Bhikoo, Riyaz ^a   Srinivasa, Sanket ^a   Yu, Tzu Chieh ^a   Moss, David ^b   Hill, Andrew G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Breast cancer; Breast neoplasm; Developing countries; Ethnicity; Low income countries

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

AFRICA; AGE; AXILLARY LYMPH NODE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CENTRAL AMERICA; DEVELOPING COUNTRY; DISTANT METASTASIS; EASTERN EUROPE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MEXICO; MIDDLE EAST; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; QUALITATIVE RESEARCH; REVIEW; SOUTH AMERICA; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 79959757197     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3022358     Document Type: Review

References (95)

1. Gill, J.K.; Maskarinec, G.; Wilkens, L.R.; Pike, M.C.; Henderson, B.E.; Kolonel, L.N.; Gill, J.K.; Maskarinec, G.; Wilkens, L.R.; Pike, M.C.; et al. Nonsteroidal antiinflammatory drugs and breast cancer risk: The multiethnic cohort. Am. J. Epidemiol. 2007, 166, 1150-1158.
2. Hortobagyi, G.N.; de la Garza Salazar, J.; Pritchard, K.; Amadori, D.; Haidinger, R.; Hudis, C.A.; Khaled, H.; Liu, M.C.; Martin, M.; Namer, M.; et al. The global breast cancer burden: Variations in epidemiology and survival. Clin. Breast Cancer 2005, 6, 391-401.
3. The Lancet. Breast cancer in developing countries. Lancet 2009, 374, 1567.
4. Ferlay, J.S.H.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10 [Internet] Lyon, France: International Agency for Research on Cancer Home Page. Available online: http://globocan.iarc.fr/ (accessed 4 July 2010).
5. Porter, P. Westernizing women's risks? Breast cancer in lower-income countries. N. Engl. J. Med. 2008, 358, 213-216.
6. Parkin, D.M.; Fernández, L.M. Use of statistics to assess the global burden of breast cancer. Breast J. 2006, 12 (Suppl. 1), S70-S80.
7. Rizwan, M.M.; Saadullah, M. Lack of awareness about breast cancer and its screening in developing countries. Indian J. Cancer 2009, 46, 252-253.
8. Beaglehole, R.; Yach, D. Globalisation and the prevention and control of non-communicable disease: The neglected chronic diseases of adults. Lancet 2003, 362, 903-908.
9. Badar, F.; Faruqui, Z.S.; Ashraf, A.; Uddin, N. Third world issues in breast cancer detection. J. Pak. Med. Assoc. 2007, 57, 137-140.
10. Vainshtein, J. Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: A systematic review. J. Natl. Med. Assoc. 2008, 100, 833-839.
11. Sarfati, D.; Blakely, T.; Shaw, C.; Cormack, D.; Atkinson, J. Patterns of disparity: Ethnic and socio-economic trends in breast cancer mortality in New Zealand. Cancer Cause Contr. 2006, 17, 671-678.
12. Newman, L.A.; Mason, J.; Cote, D.; Vin, Y.; Carolin, K.; Bouwman, D.; Colditz, G.A. African-American ethnicity, socioeconomic status, and breast cancer survival: A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer 2002, 94, 2844-2854.
13. Chlebowski, R.T.; Chen, Z.; Anderson, G.L.; Rohan, T.; Aragaki, A.; Lane, D.; Dolan, N.C.; Paskett, E.D.; McTiernan, A.; Hubbell, F.A.; et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J. Natl. Cancer Inst. 2005, 97, 439-448.
14. McKenzie, F.; Jeffreys, M; Mannetje, A.; Pearce, N. Prognostic factors in women with breast cancer: Inequalities by ethnicity and socioeconomic position in New Zealand. Cancer Cause Contr. 2008, 19, 403-411.
15. Wojcik, B.E.; Spinks, M.K.; Optenberg, S.A. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 1998, 82, 1310-1318.
16. Bhikoo, R.; Srinivasa, S.; Yu, T.C.; Moss, D.; Hill, A.G. Systematic review of breast cancer biology in developing countries (Part 2): Asian Subcontinent and South East Asia. Cancers 2011, accepted.
17. United Nations Conference on Trade and Development UNCTAD handbook of statistics, 2008 United Nations Publications TD/STAT33 Home Page. Available online: http://www.unctad.org/ (accessed 4 July 2010).
18. Curado, M.P.; Edwards, B.; Shin, H.R. Cancer Incidence in Five Continents, Vol. 9. IARC Scientific Publications No. 160, Lyon, IARC. Available online: http://www-dep.iarc.fr/ (accessed 22 August 2009).
19. AJCC Cancer Staging Manual, 6th ed.; Greene, F.L., Page, D.L., Fleming, I.D., Fritz, A., Balch, C.M., Haller, D.G., Morrow, M, Eds.; Springer: New York, NY, USA, 2002.
20. Elston, C.W.; Ellis, I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991, 19, 403-410.
21. Moher, D.; Cook, D.J.; Eastwood, S.; Olkin, I.; Rennie, D.; Stroup, D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement Quality of reporting meta-analyses. Lancet 1999, 354, 1896-1900.
22. Awadelkarim, K.D.; Arizzi, C.; Elamin, E.O.; Hamad, H.M.; De Blasio, P.; Mekki, S.O.; Osman, I,; Biunno, I.; Elwali, N.E.; Mariani-Costantini R.; et al. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: Implications for breast cancer in Africa. Histopathology 2008, 52, 444-456.
23. Ikpatt, O.F.; Kuopio, T.; Ndoma-Egba, R.; Collan, Y. Breast cancer in Nigeria and Finland: Epidemiological, clinical and histological comparison. Anticancer Res. 2002, 22, 3005-3012.
24. Huo, D.; Ikpatt, F.; Khramtsov, A.; Dangou, J.M.; Nanda, R.; Dignam, J.; Zhang, B.; Grushko, T.; Zhang, C.; Oluwasola, O.; et al. Population differences in breast cancer: Survey in indigenous african women reveals over-representation of triple-negative breast cancer. J. Clin. Oncol. 2009, 27, 4515-4521.
25. Adebamowo, C.A.; Famooto, A.; Ogundiran, T.O.; Aniagwu, T.; Nkwodimmah, C.; Akang, E.E. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res. Treat. 2008, 110, 183-188.
26. Bird, P.A.; Hill, A.G.; Houssami, N. Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease? Ann. Surg. Oncol. 2008, 15, 1983-1988.
27. Maalej, M.; Hentati, D.; Messai, T.; Kochbati, L.; El May, A.; Mrad, K.; Romdhane, K.B.; Ben Abdallah, M.; Zouari, B. 2004: A comparative clinical and epidemiological study. Bull. Cancer 2008, 95, E5-E9.
28. Mbonde, M.P.; Amir, H.; Schwartz-Albiez, R.; Akslen, L.A.; Kitinya, J.N. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol. Rep. 2000, 7, 277-283.
29. Gukas, I.D.; Jennings, B.A.; Mandong, B.M.; Manasseh, A.N.; Leinster, S.J. A comparison of the pattern of occurrence of breast cancer in Nigerian and British women. Breast 2006, 15, 90-95.
30. Ikpatt, O.F.; Ndoma-Egba, R. Oestrogen and progesterone receptors in Nigerian breast cancer: Relationship to tumour histopathology and survival of patients. Cent. Afr. J. Med. 2003, 49, 122-126.
31. Gukas, I.D.; Jennings, B.A.; Mandong, B.M.; Igun, G.O.; Girling, A.C.; Manasseh, A.N.; Ugwu, B.T.; Leinster, S.J. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr. J. Med. 2005, 24, 209-213.
32. Nairobi Cancer Registry Kenya Medical Research Institute Nairobi, Kenya (KERMI). Cancer Incidence Report Nairobi 2003. The International Network for Cancer Treatment and Research Home Page. Available online: http://www.inctr.org/ (accessed 10 November 2009).
33. Alterman, D.M.; Parker, R.M.; White, R.E. A fourteen-year review of breast pathology at a rural referral center in western Kenya. East Cent. Afr. J. Surg. 2008, 13, 41-50.
34. Amir, H.; Azizi, M.R.; Makwaya, C.K.; Jessani, S. TNM classification and breast cancer in an African population: A descriptive study. Cent. Afr. J. Med. 1997, 43, 357-359.
35. Muguti, G. Experience with breast cancer in Zimbabwe. JR Coll. Surg. Edinb. 1993, 38, 75-78.
36. Kenda, J.F.; Chirimwami, B.; Veyi, T. Clinicopathologic analysis of carcinoma of the breast in an African population. Arch. Surg. 1988, 123, 972-974.
37. National Health Laboratory Service (South Africa). National Cancer Registry. Summary Statistics of Cancer Diagnosed Histologically in 2001 Home Page. Available online: http://www.nhls.ac.za/ (accessed 20 November 2009).
38. Dansey, R.D.; Hessel, P.A.; Browde, S.; Lange, M.; Derman, D.; Nissenbaum, M.; Bezwoda, W.R. Lack of a significant independent effect of race on survival in breast cancer. Cancer 1988, 61, 1908-1912.
39. Vorobiof, D.A.; Sitas, F.; Vorobiof, G. Breast cancer incidence in South Africa. J. Clin. Oncol. 2001, 19 (Suppl. 18), 125S-127S.
40. Raharisolo Vololonantenaina, C.R.; Rabarijaona, L.P.; Rajemiarimoelisoa, C.; Rasendramino, M.; Migliani, R. Management of breast cancers diagnosed at the Pasteur Institute of Madagascar from 1995 to 2001. Arch. Inst. Pasteur. Madagascar. 2002, 68, 104-108.
41. Nissan, A.; Spira, R.M.; Hamburger, T.; Badrriyah, M.; Prus, D.; Cohen, T.; Hubert, A.; Freund, H.R.; Peretz, T. Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am. J. Surg. 2004, 188, 62-67.
42. Kingdom of Saudi Arabia Ministry of Health. Saudi Cancer Registry. Cancer Incidence Report Saudi Arabia 2005. Available online: http://www.scr.org.sa/ (accessed 22 October 2009).
43. Ezzat, A.; Raja, M.; Rostom, A.; Zwaan, F.; Akhtar, M.; Bazarbashi, S.; Ingemansson, S.; Al-Abdulkareem, A. An overview of breast cancer. Ann. Saudi. Med. 1997, 17, 10-15.
44. Ibrahim, E.M.; Al-Mulhim, F.A.; Al-Amri, A.; Al-Muhanna, F.A.; Ezzat, A.A.; Stuart, R.K.; Ajarim, D. Breast cancer in the eastern province of Saudi Arabia. Med. Oncol. 1998, 15, 241-247.
45. Mousavi, S.M.; Montazeri, A.; Mohagheghi, M.A.; Jarrahi, A.M.; Harirchi, I.; Najafi, M.; Ebrahimi, M. Breast cancer in Iran: An epidemiological review. Breast J. 2007, 13, 383-391.
46. Saatee, S.; Afrakhteh, M.; Sadrolhefazi, B. High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: True or false? Breast J. 2006, 12, 499-501.
47. Al-Moundhri, M.; Al-Bahrani, B.; Pervez, I.; Ganguly, S.S.; Nirmala, V.; Al-Madhani, A.; Al-Mawaly, K.; Grant, C. The outcome of treatment of breast cancer in a developing country-Oman. Breast 2004, 13, 139-145.
48. Motawy, M.; El Hattab, O.; Fayaz, S.; Oteifa, M.; Ali, J.; George, T.; Barghash, I.; Abuzallouf S,; El Jarallah, M. Multidisciplinary approach to breast cancer management in Kuwait, 1993-1998. J. Egypt Natl. Cancer Inst. 2004, 16, 85-91.
49. Özmen, V. Cancer control in Turkey. In Breast Cancer Screening and Registration Programs in Turkey; Tuncer, M., Ed.; Onur Press: Ankara, Turkey, 2008; Volume 740, pp. 335-343.
50. Roa, B.B.; Boyd, A.A.; Volcik, K.; Richards, C.S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat. Genet. 1996, 14, 185-187.
51. Tonin, P.; Weber, B.; Offit, K. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 1996, 2, 1179-1183.
52. Baron-Apel, O. Breast cancer. In Green Me: The State of Health in Israel. Israel Center for Disease Control: Jerusalem, Palestine, 1999; pp. 91-95.
53. Mokhtar, N.; Gouda, I.; Adel, I. Cancer Pathology Registry, 2003-2004, And Time Trend Analysis. Department of Pathology at the National Cancer Institute (NCI) Home Page. Available online: http://www.nci.cu.edu.eg/ (accessed 17 November 2009).
54. Al-Ahwal, M.S. HER-2 positivity and correlations with other histopathologic features in breast cancer patients-Hospital based study. J. Pak. Med. Assoc. 2006, 56, 65-68.
55. Fallahazad, V.; Kamalian, N.; Gransar, A. The prevalence of Estrogen and progesterone receptors in Breast cancer in shariati general hospital of Tehran 2000-2002. J. Tehran Med. Fac. 2004, 62, 745-748.
56. Ministry of Health Sultanate of Oman. Cancer incidence in Oman 2008. Department of Non-Communicable Diseases Surveillance and Control Directorate General of Health Affairs Home Page. Available online: http://www.moh.gov.om/ (accessed 3 March 2010).
57. Al-Moundhri, M.; Nirmala, V.; Al-Mawaly, K.; Ganguly, S.; Burney, I.; Rizvi, A.; Grant, C. Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer. Pathol. Oncol. Res. 2003, 9, 226-231.
58. Fakhro, A.E.; Fateha, B.E.; Al-Asheeri, N.; Al-Ekri, S.A. Breast cancer: Patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. East Mediterr. Health J. 1999, 5, 430-439.
59. United Arab Emirates National Cancer Registry. Cancer Incidence Report UAE 1998-2001 Home Page. Available online: http://www.tawamhospital.ae/ccr/annualReport.asp/ (accessed 2 November 2009).
60. Cancer Incidence in Four Member Countries (Cyrpus, Egypt, Israel and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER; Freedman, L.S., Edwards, B.K., Ries, L.A.G., Young, J.L., Eds.; National Cancer Institute: Bethesda, MD, USA, 2006.
61. Omar, F. Nimri, com.med. Epidemiology of Cancer in Jordan, 1996-2002. Proceedings of UICC World Cancer Congress, Washington, DC, USA, July 8-12, 2006.
62. Sughayer, M.A.; Al-Khawaja, M.M.; Massarweh, S.; Al-Masri, M. Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan. Pathol. Oncol. Res. 2006, 12, 83-86.
63. Almasri, N.M.; Al Hamad, M. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan. Breast Cancer Res. 2005, 7, R598-R604.
64. Adib, S.M.; Daniel, J. Ministry of Public Health. National Cancer Registry. Cancer in Lebanon 2003. Available online: http://www.moph.gov.lb/Publications/Documents/NCR2003.pdf (accessed 26 August 2010).
65. El Saghir, N.S.; Shamseddine, A.I.; Geara, F.; Bikhazi, K.; Rahal, B.; Salem, Z.M.; Taher, A.; Tawil, A.; El Khatib, Z.; Abbas, J. Age distribution of breast cancer in Lebanon: Increased percentages and age adjusted incidence rates of younger-aged groups at presentation. J. Med. Liban 2002, 50, 3-9.
66. Chalabi, N.; Bernard-Gallon, D.J.; Bignon, Y.J.; Kwiatkowski, F.; Agier, M.; Vidal, V.; Laplace-Chabaud, V.; Sylvain-Vidal, V.; Bertholet, V.; et al. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. Cancer Genomics Proteomics 2008, 5, 253-261.
67. Abadjian, G.; Antoun, R. Breast carcinoma: Evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers. Med. Liban 1996, 44, 10-15.
68. Yilmaz, H.H.; Yazihan, N.; Tunca, D.; Sevinç, A.; Olcayto, E.; Ozgül, N.; Tuncer, M. Cancer trends and incidence and mortality patterns in Turkey. Jpn. J. Clin. Oncol. 2010, 41, 10-16.
69. Özmen, V. How the quality of surgical treatment of breast cancer is increased in Turkey? J. Breast Health 2009, 5, 122-124.
70. Rudan, I.; Rudan, N.; Strnad, M. Differences between male and female breast cancer. I. Epidemiological features. Acta Med. Croatica 1995, 49, 117-120.
71. National Oncological Hospital, Bulgarian National Cancer Registry Cancer Incidence in Bulgaria 2004 Home Page. Available online: http://www.onco-bg.com/ (accessed 18 October 2009).
72. Ukraine Cancer Registry. Bulletin of National Cancer Registry of Ukraine 2006-07 Home Page. Available online: http://www.i.com.ua/~ucr/ (accessed 19 October 2009).
73. Croatian National Institute of Public Health, Croatian National Cancer Registry Cancer Incidence in Croatia 2005 Bulletin No 30, 2007. Cancer incidence in Mediterranean populations. Available online: http://www.mosepi.org/Croatia (accessed 5 April 2011).
74. Bezić, J.; Tomić, S.; Kardum, G. Minimal breast cancer in split region of Croatia on the eve of the National Mammographic Screening Program. Breast J. 2009, 15, 429-431.
75. Agarwal, G.; Ramakant, P.; Forgach, E.R.; Rendón, J.C.; Chaparro, J.M.; Basurto, C.S.; Margaritoni, M. Breast cancer care in developing countries. World J. Surg. 2009, 33, 2069-2076.
76. Vrbanec, D.; Petricević, B. Estrogen and progesterone receptor status in primary breast cancer- A study of 11,273 patients from the year 1990 to 2002. Coll. Antropol. 2007, 31, 535-540.
77. Aydinyan, L. Community based clinical trial among Yerevan women to determine the effect of a breast cancer intervention program. Department of Public Health. American University of Armenia Home Page. Available online: http://chsr.aua.am/PDF/MPH/2001/AydinyanLusine.pdf (accessed 6 November 2009).
78. Igisinov, N.; Bilyalova, Z.; Igisinov, S.; Seytkazina, G.D. Breast Cancer in Kazakhstan: Epidemiological Aspects. Presented at the 20th Asian Pacific Cancer Conference, Tsukuba, Japan November 13, 2009.
79. Igisinov, N.; Kokteubaeva, N.; Kudaibergenova, I. Epidemiology of Breast cancer in females of reproductive age in Kyrgyzstan. Asian Pac. J. Cancer Prev. 2005, 6, 37-40.
80. Knaul, F.M.; Nigenda, G.; Lozano, R.; Arreola-Ornelas, H.; Langer, A.; Frenk, J. Breast cancer in Mexico: A pressing priority. Reprod. Health Matters 2008, 16, 113-123.
81. Sistema Único de Información para la Vigilancia Epidemiológica de la Dirección General de Epidemiología, Anuarios de Morbilidad, 2000-2006. Secretaría de Salud Home Page. Available online: http://www.tomateloapecho.org.mx/attachments/File/documentos/Numeralia%20ingles.pdf (accessed 14 December 2009).
82. Rodríguez-Cuevas, S.; Guisa-Hohenstein, F.; Labastida-Almendaro, S. First breast cancer mammography screening program in Mexico: Initial results 2005-2006. Breast J. 2009, 15, 623-631.
83. Salazar, E.L.; Calzada, L.; Pedron, N. Infiltrating ductal/lobular carcinoma: An evaluation of prognostic factors in primary breast cancer. Arch. AIDS Res. 1996, 10, 73-82.
84. Salazar Esquivel, E.L.; Morales Nájar, R.; Calzada Sánchez, L. Infiltrating duct breast carcinoma: The role of estradiol and progesterone receptors. Ginecol Obstet Mex 1994, 62, 85-90.
85. Hennis, A.J.; Hambleton, I.R.; Wu, S.Y.; Barbados National Cancer Study Group. Breast cancer incidence and mortality in a Caribbean population: Comparisons with African-Americans. Int. J. Cancer 2009, 124, 429-433.
86. Alvarez-Goyanes, R.I.; Pérez, X.E.; Rodríguez, C.R.; Fernández, L.L.; López, M.O.; Mojarrieta, J.C.; Rodríguez-Montero, H.M.; Juliá, M.A. Presence of estrogen receptor and Her2 in a sample of breast cancer patients. MEDICC review 2003 Vol 5. Available online: http://www.medicc.org/publications/medicc_review/V/23/pages/cubanmedicalresearch-4.html/ (accessed 16 November 2009).
87. Gibson, T.N.; Blake, G.; Hanchard, B.; Waugh, N.; McNaughton, D. Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1998-2002. West Indian Med. J. 2008, 57, 81-89.
88. Shirley, S.E.; Mitchell, D.I.; Soares, D.P.; James, M.; Escoffery, C.T.; Rhoden, A.M.; Wolff, C.; Choy, L.; Wilks, R.J. Clinicopathologic features of breast disease in Jamaica: Findings of the Jamaican Breast Disease Study, 2000-2002. West Indian Med. J. 2008, 57, 90-94.
89. Dr. Elizabeth Quamina Cancer Registry. The National Cancer Registry of Trinidad and Tobago. Cancer in Trinidad and Tobago 2000-2002 Home Page. Available online: http://www.health.gov.tt/downloads/default.aspx?id=27/ (accessed 5 September 2009).
90. Dindyal, S.; Ramdass, M.J.; Naraynsingh, V.; Jankey, N.; Maharaj, D.; Barrow, S. Relationship of ethnicity and histologic type of breast carcinoma in a West Indian population. Breast J. 2004, 10, 266.
91. Caballero, J.L.; Ríos, B. Breast cancer. Rev. Med. Panama 1995, 20, 50-53.
92. Ministério da Saúde Instituto Nacional De Cancer (INCA) Estimativa 2010-Incidência de câncer no Brasil Home Page. Available online: http://www.inca.gov.br/estimativa/2010/index.asp/ (accessed 20 July 2010).
93. Menke, C.H.; Pohlmann, P.R.; Backes, A.; Cericatto, R.; Oliveira, M.; Bittelbrunn, A.; Schwartsmann, G. Tumor size as a surrogate end point for the detection of early breast cancer: A 30-year (1972-2002), single-center experience in southern Brazil. Breast J. 2007, 13, 448-456.
94. González-Mariño, M.A. Breast cancer in the Pedro Claver hospital in Bogotá, 2004. Rev. Salud Publica (Bogota) 2006, 8, 163-169.
95. Schwartsmann, G. Breast cancer in South America: Challenges to improve early detection and medical management of a public health problem. J. Clin. Oncol. 2001, 19 (Suppl. 18), 118S-124S.